BRIEF published on 11/13/2025 at 18:02, 1 month 6 days ago Heights Capital Management crosses thresholds Convertible Bonds Crossing Thresholds Shares And Voting Rights GenSight Biologics Heights Capital
BRIEF published on 11/13/2025 at 18:02, 1 month 6 days ago Franchissement de seuils par Heights Capital Management Obligations Convertibles Franchissement De Seuils GenSight Biologics Actions Et Droits De Vote Heights Capital
PRESS RELEASE published on 11/13/2025 at 17:57, 1 month 6 days ago Franchissement de seuils Déclaration de franchissement de seuils par Heights Capital Management pour le compte de CVI Investments, Inc. concernant GENSIGHT BIOLOGICS S.A. sur Euronext Paris Euronext Paris Franchissement De Seuils GENSIGHT BIOLOGICS SA Heights Capital Management CVI Investments Inc.
BRIEF published on 10/30/2025 at 07:35, 1 month 21 days ago GenSight Biologics: Green light for compassionate treatment in the United States FDA GenSight Biologics NOHL Compassionate Access GS010/LUMEVOQ®
BRIEF published on 10/30/2025 at 07:35, 1 month 21 days ago GenSight Biologics : Feu vert pour un traitement compassionnel aux États-Unis FDA GenSight Biologics NOHL Accès Compassionnel GS010/LUMEVOQ®
PRESS RELEASE published on 10/30/2025 at 07:30, 1 month 21 days ago Informations privilégiées / Autres communiqués GenSight Biologics a obtenu les autorisations réglementaires pour un traitement compassionnel aux États-Unis avec GS010/LUMEVOQ, visant la Neuropathie Optique Héréditaire de Leber FDA GenSight Biologics Neuropathie Optique Héréditaire De Leber GS010/LUMEVOQ Traitement Compassionnel
BRIEF published on 09/29/2025 at 23:05, 2 months 20 days ago GenSight Biologics Announces First Half 2025 Financial Results Financial Results Research And Development Treasury GenSight Biologics Early Access Programs
BRIEF published on 09/29/2025 at 23:05, 2 months 20 days ago GenSight Biologics annonce ses résultats financiers du premier semestre 2025 Résultats Financiers Recherche Et Développement Trésorerie GenSight Biologics Programmes D'accès Précoce
PRESS RELEASE published on 09/29/2025 at 23:00, 2 months 20 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie résultats financiers du premier semestre 2025 : gestion optimisée de trésorerie, financement post-clôture, transfert de fabrication, protocole d'étude soumis à l'ANSM Résultats Financiers Financement Trésorerie GenSight Biologics Étude ANSM
PRESS RELEASE published on 09/29/2025 at 23:00, 2 months 20 days ago Inside Information / News release on accounts, results GenSight Biologics reports 8.3% reduction in operating cash outflow and extends cash runway to late Q4 2025. Company's financial results show decrease in operating income, R&D expenses, and net cash flows Financial Results Operating Income Cash Management GenSight Biologics R&D Expenses
Published on 12/20/2025 at 00:30, 15 hours 4 minutes ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 17 hours 34 minutes ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 21 hours 4 minutes ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 13:30, 1 day 2 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/20/2025 at 10:05, 5 hours 29 minutes ago FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 17 hours 31 minutes ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 17 hours 54 minutes ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 18 hours 59 minutes ago Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Published on 12/19/2025 at 20:15, 19 hours 19 minutes ago CSDS EU RNS Name Changes (19 December 2025)
Published on 12/19/2025 at 21:57, 17 hours 37 minutes ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 1 day 7 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 1 day 7 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 1 day 8 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 1 day 8 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
